Hepatitis C Combination Therapy - - Interim 12-Week Data Suggest At Least Comparable Antiviral ...

- Interim 12-Week Data Suggest At Least Comparable Antiviral ...
PR Newswire (press release), NY - Mar 14, 2006... the efficacy and safety of Albuferon(TM) (albumin-interferon alpha 2b) in combination with ribavirin in patients with genotype 1 chronic hepatitis C who are ...

Antibodies Neutralizing Peginterferon Alfa during Retreatment of ...
New England Journal of Medicine (subscription), MA - Mar 22, 2006To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular ...

Coley Pharmaceutical Group Announces Top-line Data from a Clinical ...
PharmaLive.com (press release), PA - Mar 21, 2006... clinical study of Actilon(TM) (CPG 10101) in combinations with pegylated interferon and/or ribavirin for the treatment of chronic Hepatitis C virus (HCV) in ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
Yahoo! News (press release) - Mar 14, 2006... safety, tolerability and efficacy of Albuferon(TM) (albumin-interferon alpha 2b) in combination with ribavirin in patients with chronic hepatitis C who failed ...

Management of Hepatitis C Disease Among VA Patients With ...
Psychiatric Services (subscription) - Mar 3, 2006... Muir AJ, Provenzale D: A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. ...

Valeant Pharma's Viramidine Fails To Meet Efficacy Goal In ...
Trading Markets, CA - Mar 21, 2006... a nucleoside analog prodrug of Ribavirin, in oral form, for administration in combination with a pegylated interferon for the treatment of chronic hepatitis C. ...